Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.

The Journal of antimicrobial chemotherapy·2002

Same author

Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.

Diagnostic microbiology and infectious disease·2001

Same author

New insights in medical mycology: focus on fungal infections. Introduction.

Pharmacotherapy·2001

Same author

Antifungal resistance among Candida species.

Pharmacotherapy·2001

Same author

Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

Antimicrobial agents and chemotherapy·2001

Same author

Novel triazole antifungal agents.

Expert opinion on investigational drugs·2000

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests.

S R Herbin¹, D G Klepser², M E Klepser³

¹College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA.

Journal of Clinical Microbiology

|February 21, 2020

Summary

This summary is machine-generated.

Community pharmacies are increasingly using CLIA-waived point-of-care tests (POCT) for disease screening. These tests aid in identifying acute and chronic illnesses like influenza and human immunodeficiency virus (HIV), enhancing public health management.

Keywords:

CLIA waived POCT pharmacy point-of-care

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

Remote Laboratory Management: Respiratory Virus Diagnostics

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

Clinical Pharmacy
Point-of-Care Testing
Infectious Disease Management

Background:

Influenza causes ~48,000 deaths annually; ~200,000 individuals have undiagnosed HIV.
CLIA-waived tests enable rapid identification of acute and chronic illnesses.
Community pharmacies are integrating point-of-care testing (POCT) into their services.

Purpose of the Study:

Discuss the rationale for pharmacy-based POCT programs.
Summarize clinical data for infectious disease screening programs in pharmacies.
Explore the future potential of CLIA-waived POCT in community pharmacy settings.

Main Methods:

Review of current pharmacy-based disease screening and management programs.
Analysis of clinical data related to infectious disease POCT in pharmacies.
Discussion of the strategic implementation and future outlook of these programs.

Main Results:

Pharmacies are actively adopting CLIA-waived POCT for various health conditions.
Clinical data indicates the utility of these programs in infectious disease detection.
The integration of POCT aligns with expanding pharmacy roles in public health.

Conclusions:

CLIA-waived POCT programs offer a viable strategy for disease screening and management in community pharmacies.
These programs have the potential to improve early detection and treatment of infectious diseases.
The expansion of POCT in pharmacies represents a significant future direction for accessible healthcare.